accrued; and 5) higher finance costs due to higher borrowings as a result of previous investment. However, the Company has been focusing on following recovery plans and has improved loss from Q4/2018 at
previous investment. However, the Company has been focusing on following recovery plans and has improved loss from Q4/2018 at Baht 143 million by escalating utilization rate, and better expenses and costs
stainless pipe following the lower global material price and intensive competition. The majority sales of Company comprised of metal like stainless steel and non-ferrous metal like copper and aluminum whereas
85.65% of paid-up capital shares. Following this transaction, the Company has acquired a business which operate in the Biopharmaceutical products. 4) the purchase price Total amount of Baht 50 million 3
Facility”), which manufacture the following key products: Ethylene Oxide (EO), Propylene Oxide (PO), Glycols, Ethanolamines (EOA), Surfactants, Linear Alkylbenezene (LAB),and Methyl Tertiary-butyl Ether
2019, the amount was 5,399.2 million Baht, a decrease of 897.3 million Baht or 14.3 percent, with the following reasons: 1. Sales revenue in Q2/2019 was 1,720.6 million Baht, a decrease of 27.7% from the
, by total of Baht 299.26 Million, or 189.58%. Resulted as reasons following; o The Group's operating results with net profit attributable to owners of the parent for 6-month period total of Baht 40.83
investments planned in H2 2019 following the completion of a small investment project for product development. On the liabilities side the short-term borrowing facility increased due to the use of a TR (Trust
services and other income) increased by Baht 33 .12 million or 29.03% from the same quarter of last year, which can be divided into business segments as per information in following table: Management's
the Company and its subsidiary, please kindly find the following attachment. Please kindly be informed accordingly. Yours faithfully, Mr. Geza Emil Perlaki Managing Director For period ended 31 March